{"id":28619,"date":"2026-01-17T06:34:11","date_gmt":"2026-01-17T06:34:11","guid":{"rendered":"https:\/\/www.europesays.com\/africa\/28619\/"},"modified":"2026-01-17T06:34:11","modified_gmt":"2026-01-17T06:34:11","slug":"engineering-better-therapies-a-nigerian-scientists-journey","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/africa\/28619\/","title":{"rendered":"Engineering Better Therapies: A Nigerian scientist\u2019s journey"},"content":{"rendered":"


\n <\/a><\/p>\n

In drug development, success often hinges on a deceptively simple question: how will the body respond? For Dr. Kidochukwu Atube, that question sits at the center of his scientific work, guiding how he thinks about medicines long before they reach patients.\n<\/p>\n

\u201cEven the most promising drugs can fall short if they are not delivered effectively,\u201d he said. \u201cUnderstanding how to get the medicine to the right place at the right time is just as important as the drug itself.\u201d His experience across engineering, pharmaceutical science, and drug delivery has shaped the way he approaches designing therapies that work reliably in patients.\n<\/p>\n

Atube currently works with a growing biotechnology company in Massachusetts, contributing to drug product development programs aimed at advancing innovative oncology therapies.\n<\/p>\n

A widely shared social media profile by African Giant highlighted Atube\u2019s research journey, bringing visibility to his contributions and prompting renewed interest in his path as part of a rising generation of Nigerian scientists influencing global biomedical research.\n<\/p>\n

That path, however, did not begin in biotech hubs or research labs. Atube\u2019s earliest education took place in Delta State, Nigeria, where he developed a disciplined approach to learning and an early fascination with how systems work. \u201cI was always interested in understanding why things behaved the way they did,\u201d he recalled. \u201cThat mindset stayed with me.\u201d<\/p>\n

He later studied chemical engineering at Covenant University in Ota, Ogun State, widely regarded as one of Nigeria\u2019s leading institutions for science and engineering education. The experience, he says, shaped how he approaches complex problems to this day.
\u201cCovenant gave me structure,\u201d Atube said. \u201cYou learn how to think critically, how to analyze systems, and how to be precise. Most importantly, how to be disciplined. Those skills transfer directly into biomedical work.\u201d <\/p>\n

His interest in applying engineering to medical challenges led him to doctoral training at the University of South Carolina. There, his research integrated chemical engineering, pharmaceutics, and biological evaluation to study how drug delivery systems interact with immune and inflammatory pathways. The goal was not only to improve delivery efficiency, but to understand how the body itself shapes therapeutic outcomes.\n<\/p>\n

During this period, Atube won the University of South Carolina SPARC Graduate Research Grant, a highly competitive award that partially supported his doctoral research. He also received the International Student Excellence Award and other merit-based recognitions tied to his work in drug delivery and biomaterials.\n<\/p>\n

Asked what motivates him now, his answer remains grounded. \u201cI think about impact,\u201d he said. \u201cIf we want better therapies, we have to design them with biology in mind from the start.\u201d\n<\/p>\n

As a collaborating author, his research has been published in international peer-reviewed journals and cited across drug delivery, biomaterials, and inflammation-related fields.<\/p>\n

For Atube, the growing visibility of his work is about more than individual recognition. \u201cThere are many Nigerian-trained scientists doing important work globally,\u201d he said. \u201cTelling these stories helps expand what people imagine is possible.\u201d\n<\/p>\n

From early classrooms in Delta State to contributions in oncology-focused drug development in the United States, Dr. Kidochukwu Atube\u2019s journey reflects a broader shift in global science, one driven by interdisciplinary thinking, diverse training backgrounds, and a commitment to designing therapies that work with the body, not against it.<\/p>\n

Ifeoma Okeke-Korieocha<\/a> <\/p>\n

Ifeoma Okeke-Korieocha is the Aviation Correspondent at BusinessDay Media Limited, publishers of BusinessDay Newspapers.
\n
\nShe is also the Deputy Editor, BusinessDay Weekender Magazine, the Saturday Weekend edition of BusinessDay.
\n
\nShe holds a BSC in Mass Communication from the prestigious University of Nigeria, Nsukka and a Masters degree in Marketing at the University of Lagos.
\n
\nAs the lead writer on the aviation desk, Ifeoma is responsible and in charge of the three weekly aviation and travel pages in BusinessDay and BDSunday. She also overseas and edits all pages of BusinessDay Saturday Weekender.
\n
\nShe has written various investigative, features and news stories in aviation and business related issues and has been severally nominated for award in the category of Aviation Writer of the Year by the Nigeria Media Nite-Out awards; one of the Nigeria\u2019s most prestigious media awards ceremonies.
\n
\nIfeoma is a one-time winner of the
\nprestigious Nigeria Media Merit Award under the ‘Aviation Writer of the Year’ Category.
\n
\nShe is the 2025 Eloy Award winner under the Print Media Journalist category.
\n
\nShe has undergone several journalism trainings by various prestigious organisations.
\n
\nIfeoma is also a fellow of the Female Reporters Leadership Fellowship of the Wole Soyinka Centre for Investigative Journalism. <\/p>\n

\"\" <\/a> <\/p>\n","protected":false},"excerpt":{"rendered":"In drug development, success often hinges on a deceptively simple question: how will the body respond? For Dr.…\n","protected":false},"author":2,"featured_media":28620,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[45],"tags":[122],"class_list":{"0":"post-28619","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nigeria","8":"tag-nigeria"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/posts\/28619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/comments?post=28619"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/posts\/28619\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/media\/28620"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/media?parent=28619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/categories?post=28619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/africa\/wp-json\/wp\/v2\/tags?post=28619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}